Experimental Nicotine Replacement Therapy (NRT) 2 mg + Experimental Nicotine Replacement Therapy (NRT) + Marketed Nicotine Lozenge + Marketed Nicotine Lozenge
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Aug 1, 2009 → Jan 1, 2010
NCT ID
NCT01227720About Experimental Nicotine Replacement Therapy (NRT) 2 mg + Experimental Nicotine Replacement Therapy (NRT) + Marketed Nicotine Lozenge + Marketed Nicotine Lozenge
Experimental Nicotine Replacement Therapy (NRT) 2 mg + Experimental Nicotine Replacement Therapy (NRT) + Marketed Nicotine Lozenge + Marketed Nicotine Lozenge is a pre-clinical stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01227720. Target conditions include Tobacco Dependence.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01227720 | Pre-clinical | Completed |
Competing Products
20 competing products in Tobacco Dependence